Contineum Therapeutics, Inc. · NASDAQ:CTNM
Millennium Management LLC reported a 5.10% stake in Contineum Therapeutics, Inc. (Schedule 13G)
Event Apr 13, 2026 · Filed Apr 17, 2026
Millennium Management LLC reported a 5.10% stake in Contineum Therapeutics, Inc., 1,658,349 shares, as a passive investor on Apr 13, 2026. Filed Apr 17, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 1,658,349
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Millennium Management LLC | 5.10% | 1,658,349 |
| Millennium Group Management LLC | 5.10% | 1,658,349 |
| Israel A. Englander | 5.10% | 1,658,349 |
Source
Related
- Contineum Therapeutics, Inc.
- Millennium Management LLC
- Contineum Therapeutics, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Jul 17, 2026
- Schedule 13G · Trails Edge Capital Partners, LP · Oct 22, 2026
- Form 4 · Stengone Carmine N. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Stengone Carmine N. · Aug 3, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026